Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a major cause of morbidity and mortality following heart transplantation (HT). Reduced cardiovascular mortality and morbidity have been reported in non-HT patients treated with metformin. Given the high prevalence of type 2 diabetes mellitus (T2DM)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Main Authors: Ram, Eilon, Lavee, Jacob, Tenenbaum, Alexander, Klempfner, Robert, Fisman, Enrique Z., Maor, Elad, Ovdat, Tal, Amunts, Sergei, Sternik, Leonid, Peled, Yael
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6747732/
https://ncbi.nlm.nih.gov/pubmed/31526382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0925-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados